Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Biogend Therapeutics Co.ltd

Clinical trials sponsored by Biogend Therapeutics Co.ltd, explained in plain language.

Completed 2
Sort by
  • New bone graft shows promise for mending tough leg breaks

    Disease control Completed

    This study tested a new bone graft material (OIF/β-TCP) in 35 people with severe open fractures of the shin bone (tibia). The goal was to see if it helps bones heal when they are slow to mend. Participants were followed for up to 52 weeks after the graft was implanted.

    Phase: NA • Sponsor: BioGend Therapeutics Co.Ltd • Aim: Disease control

    Last updated Jun 27, 2026 07:51 UTC

  • New scaffold implant shows promise for damaged knee cartilage

    Disease control Completed

    This study tested a special implant called BiCRI in 11 people with knee cartilage damage. The implant is a scaffold that helps new cartilage grow. Researchers measured pain, knee function, and tissue healing. The goal was to see if the implant is safe and works for tough cases, i…

    Phase: NA • Sponsor: BioGend Therapeutics Co.Ltd • Aim: Disease control

    Last updated Jun 27, 2026 07:51 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space